Zilebesiran

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameZilebesiran
Drug Alias NameAGT siRNA (Alnylam Pharmaceuticals)ALN-AGT01ALN-AGT-01ALN-AGTRG-6615
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiotensinogen inhibitorsRNA interference
TargetsAngiotensinogen
Therapy Area/IndicationsHypertensionCardiovascular DiseasesPre-Eclampsia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[37] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAlnylam Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesDepartment Of Neurology, Charité - Universitätsmedizin Berlin, GermanyF. Hoffmann-La Roche LtdAlnylam Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHypertensionCardiovascular DiseasesPre-Eclampsia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A